Sunshine Global Circuits
300739
TIANMA NEW MATERIAL.
838971
ZECHENG ELECTRONICS
837821
Jiangsu Jinling Sports Equipment
300651
Global Infotech
300465
CN Stock MarketDetailed Quotes
002950 Allmed Medical Products
- 8.75
- -0.34-3.74%
Noon Break Dec 17 11:30 CST
5.54BMarket Cap24.58P/E (TTM)
9.11High8.74Low56.81KlotVolume9.08Open9.09Pre Close50.38MTurnover1.26%Turnover Ratio50.29P/E (Static)633.27MShares10.5252wk High1.66P/B3.95BFloat Cap5.9952wk Low10.00Limit Up452.00MShs Float38.96Historical High8.18Limit Down4.07%Amplitude5.99Historical Low0.03Dividend TTM8.87Avg Price34.24KlotAsk0.31%Div YieldTTM100Lot Size21.40KlotBid
Allmed Medical Products Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 21.39%2.45B | 10.86%1.58B | -8.38%746.41M | -34.53%2.76B | -34.20%2.02B | -33.16%1.43B | -17.96%814.64M | 43.92%4.21B | 31.79%3.07B | 42.62%2.13B |
| Operating revenue | 21.39%2.45B | 10.86%1.58B | -8.38%746.41M | -34.53%2.76B | -34.20%2.02B | -33.16%1.43B | -17.96%814.64M | 43.92%4.21B | 31.79%3.07B | 42.62%2.13B |
| Other operating revenue | ---- | 221.85%18.2M | ---- | 213.07%49.4M | ---- | -26.56%5.66M | ---- | -57.86%15.78M | ---- | -88.99%7.7M |
| Total operating cost | 18.35%2.14B | 10.77%1.36B | -5.03%644.08M | -29.33%2.51B | -32.45%1.81B | -31.04%1.23B | -17.59%678.21M | 41.51%3.56B | 32.53%2.68B | 40.69%1.78B |
| Operating cost | 24.47%1.76B | 14.43%1.13B | -1.93%531.56M | -28.84%1.99B | -30.09%1.42B | -29.05%983.88M | -19.90%542M | 36.68%2.79B | 21.51%2.03B | 32.92%1.39B |
| Operating tax surcharges | 14.07%15.04M | 3.73%9.68M | -12.64%4.61M | -27.28%19.25M | -37.57%13.19M | -39.91%9.33M | -28.59%5.27M | 35.51%26.47M | 38.31%21.12M | 68.43%15.53M |
| Operating expense | 54.63%69.74M | 38.60%43.51M | -17.51%18.75M | -21.61%65.69M | -41.65%45.1M | -39.80%31.39M | 21.18%22.73M | 12.52%83.8M | 66.14%77.29M | 64.38%52.15M |
| Administration expense | -15.47%214.04M | -19.47%135.12M | -28.39%65.03M | -11.55%323.67M | -16.83%253.19M | -19.29%167.8M | -11.77%90.81M | 23.90%365.95M | 38.90%304.41M | 44.58%207.91M |
| Financial expense | -2.12%18.28M | 3,001.39%9.7M | 228.16%5.67M | -77.74%39.9M | -90.66%18.67M | -100.37%-334.24K | -4,332.94%-4.42M | 1,352.50%179.28M | 1,636.59%199.98M | 29,798.33%90.34M |
| -Interest expense (Financial expense) | -14.07%21.13M | -11.00%14.79M | -23.34%8.11M | -10.16%31.87M | -26.36%24.59M | 20.12%16.62M | 160.45%10.57M | 106.44%35.47M | 154.36%33.39M | 53.08%13.84M |
| -Interest Income (Financial expense) | -285.90%-4.87M | -122.07%-1.63M | -64.81%-749.31K | 39.53%-1.87M | 41.73%-1.26M | 52.37%-735.8K | 63.73%-454.65K | 25.91%-3.09M | 35.51%-2.17M | 41.87%-1.54M |
| Research and development | -3.67%57.85M | 2.03%38.81M | -15.41%18.46M | -28.19%77.37M | 31.61%60.06M | 21.31%38.04M | 26.35%21.82M | 13.91%107.74M | -21.46%45.64M | -21.18%31.35M |
| Credit Impairment Loss | -159.37%-1.83M | -202.04%-2.12M | 152.88%710.62K | 7.04%-1.61M | 1,265.25%3.08M | 244.59%2.08M | 217.81%281.01K | 51.32%-1.73M | 105.03%225.86K | 66.89%-1.44M |
| Asset Impairment Loss | 89.69%-2.72M | 96.46%-458.34K | 89.22%-684.77K | -628.77%-107.73M | -276.82%-26.37M | -199.69%-12.93M | -132.93%-6.35M | -110.54%-14.78M | -1,225.20%-7M | -422.29%-4.31M |
| Other net revenue | 251.07%20.52M | 3,626.76%17.46M | 4.12%13.56M | 42.57%-73.7M | 89.05%-13.58M | -90.76%468.48K | -50.32%13.03M | -236.53%-128.34M | -233.22%-124M | -92.13%5.07M |
| Fair value change income | -112.33%-6.86M | -113.00%-6.71M | -108.11%-4.96M | 191.63%52.75M | 137.93%55.67M | 234.20%51.65M | 2,161.53%61.1M | -1,038.69%-57.56M | -2,332.98%-146.75M | -1,103.35%-38.49M |
| Invest income | 105.38%3.33M | 110.82%5.53M | 110.91%5.16M | 41.89%-59.63M | -577.40%-61.84M | -337.67%-51.07M | -632.36%-47.33M | -386.67%-102.62M | -139.44%-9.13M | 59.46%21.49M |
| -Including: Investment income associates | -673.04%-6.04M | -135.61%-2.44M | -32.02%2.7M | -60.09%9.87M | -88.01%1.05M | -18.38%6.86M | 236.32%3.98M | 547.52%24.73M | 3,021.44%8.78M | 314.23%8.4M |
| Asset deal income | -1,893.40%-567.52K | -1,893.40%-567.52K | -124.07%-8.68K | -102.08%-72.9K | -99.38%31.64K | -99.39%31.64K | -99.30%36.08K | 80.24%3.5M | 6,105.92%5.09M | 6,152.69%5.16M |
| Other revenue | 84.15%29.17M | 103.44%21.79M | 152.12%13.34M | -5.05%42.59M | -52.80%15.84M | -52.72%10.71M | -57.43%5.29M | -26.10%44.86M | -50.99%33.56M | -54.90%22.66M |
| Operating profit | 68.13%331.35M | 19.98%236.47M | -22.46%115.89M | -67.80%169.06M | -26.24%197.08M | -44.57%197.08M | -23.87%149.46M | 3.79%525.07M | -33.40%267.18M | 21.34%355.58M |
| Add:Non operating Income | -3.31%1.6M | 5.49%1.05M | 65.60%52.37K | 81.26%2.69M | 157.06%1.66M | 62.38%993.08K | -94.79%31.62K | 68.45%1.49M | 37.43%645.25K | 3,997.48%611.58K |
| Less:Non operating expense | 90.57%2.45M | 268.75%2.33M | 544.70%1.28M | -93.50%2.71M | -93.07%1.29M | -83.83%632.77K | -90.99%198.85K | 3,189.60%41.65M | 1,054.75%18.55M | 3,848.20%3.91M |
| Total profit | 67.39%330.51M | 19.11%235.18M | -23.19%114.66M | -65.14%169.04M | -20.79%197.45M | -43.95%197.44M | -23.33%149.29M | -4.07%484.9M | -37.68%249.27M | 20.25%352.28M |
| Less:Income tax cost | 23.81%64.82M | 12.62%47.9M | -8.26%20.54M | -19.23%64.83M | -0.31%52.36M | -31.69%42.53M | -37.57%22.38M | 9.16%80.26M | -24.04%52.52M | 17.58%62.27M |
| Net profit | 83.11%265.68M | 20.90%187.28M | -25.83%94.13M | -74.24%104.22M | -26.25%145.1M | -46.58%154.91M | -20.12%126.9M | -6.32%404.64M | -40.54%196.75M | 20.84%290.01M |
| Net profit from continuing operation | 83.11%265.68M | 20.90%187.28M | -25.83%94.13M | -74.24%104.22M | -26.25%145.1M | -46.58%154.91M | -20.12%126.9M | -6.32%404.64M | -40.54%196.75M | 20.84%290.01M |
| Less:Minority Profit | 109.77%518.47K | 113.42%285.9K | 125.24%247.61K | -187.70%-6.18M | -4,176.54%-5.31M | -2,278.54%-2.13M | -185.26%-980.97K | -388.25%-2.15M | -107.16%-124.14K | -104.02%-89.55K |
| Net profit of parent company owners | 76.30%265.17M | 19.08%187M | -26.59%93.88M | -72.86%110.4M | -23.60%150.41M | -45.87%157.04M | -18.92%127.88M | -5.66%406.79M | -40.18%196.87M | 22.01%290.1M |
| Earning per share | ||||||||||
| Basic earning per share | 78.23%0.4233 | 19.84%0.2972 | -26.60%0.1482 | -72.87%0.1743 | -23.61%0.2375 | -45.86%0.248 | -18.95%0.2019 | -5.82%0.6424 | -40.18%0.3109 | 22.00%0.4581 |
| Diluted earning per share | 78.23%0.4233 | 19.84%0.2972 | -26.60%0.1482 | -72.87%0.1743 | -23.61%0.2375 | -45.86%0.248 | -18.95%0.2019 | -5.82%0.6424 | -40.18%0.3109 | 22.00%0.4581 |
| Other composite income | -1.91%-2.26M | -142.99%-5.34M | 86.79%-3.08M | -82.32%13.78M | -102.39%-2.21M | -105.39%-2.2M | -394.44%-23.3M | 432.02%77.94M | 1,385.32%92.79M | 555.74%40.8M |
| Other composite income of parent company owners | -1.91%-2.26M | -142.99%-5.34M | 86.79%-3.08M | -82.32%13.78M | -102.39%-2.21M | -105.39%-2.2M | -394.44%-23.3M | 432.02%77.94M | 1,385.32%92.79M | 555.74%40.8M |
| Total composite income | 84.37%263.43M | 19.14%181.94M | -12.12%91.05M | -75.55%118M | -50.65%142.88M | -53.84%152.71M | -32.79%103.6M | 18.14%482.59M | -10.54%289.53M | 43.18%330.81M |
| Total composite income of parent company owners | 77.41%262.91M | 17.32%181.66M | -13.18%90.8M | -74.38%124.18M | -48.84%148.19M | -53.21%154.84M | -31.65%104.58M | 18.88%484.74M | -10.02%289.66M | 44.61%330.9M |
| Total composite income of minority owners | 109.77%518.47K | 113.42%285.9K | 125.24%247.61K | -187.70%-6.18M | -4,176.54%-5.31M | -2,278.54%-2.13M | -185.26%-980.97K | -388.25%-2.15M | -107.16%-124.14K | -104.02%-89.55K |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
